Steward Partners Investment Advisory’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2
Closed -$21 – 4775
2026
Q1
$21 Hold
2
– – ﹤0.01% 4384
2025
Q4
$67 Hold
2
– – ﹤0.01% 4237
2025
Q3
$184 Hold
2
– – ﹤0.01% 4172
2025
Q2
$571 Hold
2
– – ﹤0.01% 3952
2025
Q1
$688 Hold
2
– – ﹤0.01% 3821
2024
Q4
$833 Hold
2
– – ﹤0.01% 3784
2024
Q3
$684 Hold
2
– – ﹤0.01% 3563
2024
Q2
$851 Hold
2
– – ﹤0.01% 3412
2024
Q1
$956 Hold
2
– – ﹤0.01% 3381
2023
Q4
$840 Hold
2
– – ﹤0.01% 3322
2023
Q3
$1.07K Hold
2
– – ﹤0.01% 3177
2023
Q2
$1.75K Hold
2
– – ﹤0.01% 3054
2023
Q1
$1.81K Hold
2
– – ﹤0.01% 3037
2022
Q4
$4.58K Hold
2
– – ﹤0.01% 2804
2022
Q3
$1K Hold
2
– – ﹤0.01% 3133
2022
Q2
$2K Hold
2
– – ﹤0.01% 3007
2022
Q1
$8K Hold
2
– – ﹤0.01% 2739
2021
Q4
$7K Hold
2
– – ﹤0.01% 2726
2021
Q3
$16K Hold
2
– – ﹤0.01% 2419
2021
Q2
$32K Hold
2
– – ﹤0.01% 4070
2021
Q1
$40.4K Hold
2
– – ﹤0.01% 2093
2020
Q4
$41K Buy
2
+1
+100% +$18.8K ﹤0.01% 1751
2020
Q3
$23K Buy
+1
New +$23K ﹤0.01% 1839

Other funds holding KALA

Steward Partners Investment Advisory's KALA Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of KALA BIO (KALA) in Q2 2026, closing a stake of 2 shares — an estimated $21 sold.

Steward Partners Investment Advisory first reported a position in KALA in Q3 2020 and held it in 23 quarters. The position peaked at $41K in Q4 2020. 15 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Steward Partners Investment Advisory reported no remaining KALA BIO position as of Q2 2026 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 2 KALA BIO shares in Q2 2026, an estimated $21.
  • Steward Partners Investment Advisory first reported a position in KALA BIO in Q3 2020 and held it in 23 quarters.
  • Steward Partners Investment Advisory's KALA BIO position peaked at $41K in Q4 2020.
  • 15 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.